BioSpace News Archive

Pharm Country

Revealed: Key Trends in the Alternate Site Health Care Industry

Key and emerging trends in the spotlight at the 15th Annual MHA Business Summit

March 14, 2018
·
3 min read
Pharm Country

InventHelp Inventor Develops Improved Mobility Cane for the Visually Impaired (SDB-1170)

The cane keeps the user from bumping into objects, such as lampposts, trash cans, other people, etc.

March 14, 2018
·
1 min read
Business

Joshua D. Stein, MD, MS, Receives 2018 Pisart Award for Outstanding Achievements in Vision Science Research

Lighthouse Guild Honors Leading Scientist for Research Impacting Health Services for People with Blindness and Vision Loss

March 14, 2018
·
4 min read
Business

ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results

ProMIS Neurosciences, Inc. a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced its operational and financial results for the year ended December 31, 2017.

March 14, 2018
·
6 min read
BioMidwest

On Target Laboratories Raises Additional Capital from H.I.G. BioHealth Partners, Elevate Ventures and Helsinn

These recent raises bring the total financing round close to $44 million.

March 14, 2018
·
5 min read
Pharm Country

Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development

Project Originated at Rockefeller University and Graduated From Tri-Institutional Therapeutics Discovery Institute

March 14, 2018
·
4 min read
FDA

Amneal Gains Approval for Erythromycin Tablets USP

Amneal Pharmaceuticals has received FDA approval for Erythromycin Tablets USP, 250 mg and 500 mg strengths.

March 14, 2018
·
2 min read
Business

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results

BioSpecifics reported net income of $2.6 million for the fourth quarter ended December 31, 2017.

March 14, 2018
·
16 min read
Policy

Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies

Patents strengthen Company’s intellectual property portfolio for its lead product candidate ASN100 which is designed to uniquely address Staphylococcus aureus infections

March 14, 2018
·
3 min read
Biotech Bay

Arcadia Biosciences Achieves Key Resistant Starch Wheat Technology Milestones, Prepares for Commercial Launch

-- New Non-GM Wheat Varieties Naturally High in Amylose and Fiber Create Unique Value Opportunities for Consumer Branded Products and Tangible Health Benefits for Consumers --

March 14, 2018
·
4 min read